H2020-HCO-2014 / INCONTACT: information about specific international cooperation calls in the Horizon 2020 work programmes

Call Details

Work Programme :	Health - Health, demographic change and wellbeing
Call Identifier :	H2020-HCO-2014
Call Type :	Targeted call
Call Description :	HEALTH CO-ORDINATION ACTIVITIES
Publication Date :	11 December 2013
Deadline :	15 April 2014
URL :	http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-hco-2014.html

Topics

Title :	HCO 10 – 2014: ERA NET: Rare Disease research implementing IRDiRC objectives
Description :	Maximising scarce resources and coordinating research efforts are key elements for success in the area of rare diseases, characterised by scattered knowledge and relatively small patient populations. Transnational cooperation and coordination to pool resources and avoid duplication of efforts, while developing common standards and research priorities, is therefore essential. The International Rare Diseases Research Consortium (IRDiRC) was launched in 2011 to strengthen international collaboration in the area with the aim of delivering 200 new therapies for rare diseases and means to diagnose most of them by the year 202037. An ERA-NET focused on funding research according to IRDiRC objectives and priorities should be an implementation tool for the realisation of the IRDiRC 2020 goals.
Targeted countries :	Australia, Canada, China, Korea (Democratic People's Republic of), United States of America INCO EECA : Georgia

Title :	HCO 12 – 2015: ERA-NET: Antimicrobial Resistance
Description :	Antibiotic resistance is a global problem. It is considered by the World Health Organization as one of the three greatest threats to human health for the next decades. In Europe, however, research on the resistance to antibiotics and on how to make sustainable use of antibiotics is fragmented. In addition, few countries have specific programs dedicated to this field of research. The 19 participating countries of the AMR JPI aim to accomplish the coordination of European research on AMR in close collaboration with the funding instruments of the EU; specifically Horizon 2020, Innovative Medicines Initiative (IMI) and the ERA-NET Infect-ERA. Proposal should implement other joint activities including collaborative actions with the World Health Organisation or the pharmaceutical industry (among others) as well as additional joint international calls without EU co-funding (e.g. with Canada).
Targeted countries :	Canada

Title :	HCO 4 – 2014: Support for international infectious disease preparedness research
Description :	Human health worldwide is increasingly threatened by potential epidemics caused by existing, new and emerging infectious diseases, including those which are resistant to antimicrobial agents. An infectious epidemic can strike anywhere, and at any time globally. In order to save lives, the research response needs to be quick, flexible, comprehensive and global and therefore is beyond the capacity of any single country or even the European Union. Besides being a major threat to human health, such epidemics are a severe burden on the global economy with an impact on competitiveness, growth and jobs. In response to these challenges a global, multi-funder initiative has been launched, the global research collaboration for infectious disease preparedness (GloPID-R). Support is therefore required in building, maintaining and coordinating a global consortium of funding organisations working towards the goal of preparing for a rapid joint global research response to any new outbreak.
Targeted countries :	American Pacific Isles, American Samoa, Andorra, Antarctica, Antigua And Barbuda, Australia, Bahamas, Bahrain, Bermuda, Bouvet Island, Brazil, Brunei Darussalam, Canada, Ceuta, China, Christmas Island, Cocos (Keeling) Islands, French Guiana, Gibraltar, Guadeloupe, Guam, Heard Island and Mc Donald Islands, Holy See (Vatican City State), Hong-Kong, India, Isle of Man, Japan, Jersey, Korea (Democratic People's Republic of), Korea (Republic of), Kuwait, Macau, Martinique, Melilla, Mexico, Monaco, New Zealand, Norfolk Island, Northern Mariana Islands, Puerto Rico, Qatar, Reunion, Russia, San Marino, Saudi Arabia, Singapore, Svalbard and Jan Mayen, Taiwan, Tokelau, United Arab Emirates, United States Minor Outlying Islands, United States of America, Virgin Islands (US), Western Sahara INCO ACP AFRICAN : Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo (Democratic Republic of), Congo (Republic), Djibouti, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Ivory Coast, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, Swaziland, Zambia, Zimbabwe, Tanzania (United Republic of), Togo, Uganda INCO ACP CARIBBEAN : Barbados, Belize, Cuba, Dominica, Dominican Republic, Grenada, Guyana, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago INCO ACP PACIFIC : Cook Islands, East Timor, Fiji, Kiribati, Marshall Islands, Micronesia (Federated States of), Nauru, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu INCO ASIA : Afghanistan, Bangladesh, Bhutan, Burma/ Myanmar, Cambodia, Indonesia, Iran (Islamic Republic of), Iraq, Lao (People's Democratic Republic of), Malaysia, Maldives, Mongolia, Nepal, Oman, Pakistan, Philippines, Sri Lanka, Thailand, Viet Nam, Yemen INCO EECA : Armenia, Azerbaijan, Belarus, Georgia, Kazakstan, Kyrgyz Republic, Moldova (Republic of), Tajikistan, Turkmenistan, Ukraine, Uzbekistan INCO LATIN AMERICA : Argentina, Bolivia, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela INCO MEDITERRANEAN : Algeria, Egypt, Jordan, Lebanon, Libya, Morocco, Palestinian administered areas, Syrian Arab Republic, Tunisia INCO WESTERN BALKAN : Kosovo (UN resolution) PTOM : Anguilla, Aruba, British Indian Ocean Territory, Cayman Islands, Falkland Islands (Malvinas), French Polynesia, French Southern Territories, Greenland, Mayotte, Montserrat, Netherlands Antilles, New Caledonia, Pitcairn, Saint Helena, Saint Pierre and Miquelon, South Georgia and South Sandwich Islands, Turks and Caicos Islands, Virgin Islands (British), Wallis and Futuna

Title :	HCO 5 – 2014: Global Alliance for Chronic Diseases: prevention and treatment of type 2 diabetes
Description :	In the past twenty years the global death rate from diabetes has doubled and the World Health Organisation (WHO) is predicting that this will increase by two thirds by 2030. It is currently estimated that 347 million people worldwide suffer from diabetes with more than 80% from low-and middle-income countries. With the burden of this chronic non-communicable disease ever-increasing the Global Alliance for Chronic Diseases (GACD) partnership, of which the Commission is a member, has agreed to launch a call for proposals on the prevention and treatment of type 2 diabetes, with a focus on implementation and intervention research in low- and middle-income countries and in vulnerable populations in high income countries.
Targeted countries :	Australia, China, India, United States of America INCO ACP AFRICAN : South Africa

Title :	PHC 34 – 2014: eHealth interoperability
Description :	The proposal should at minimum build on existing CEN, ISO, and HL7 standards. Proposals should investigate the possibility of combining existing or developing a new European or international standard which address the following issues: a) Unambiguous definition and description of medicinal and pharmaceutical products, including unique identification.b)Handling of substitution. Proposals should investigate the use of SNOMED CT as a core terminology to solve semantic interoperability issues for cross border but also national and regional eHealth deployments in the EU. Proposals should take into account advice and guidelines from the eHealth Network but also developments related to the EU-US roadmap.
Targeted countries :	United States of America